Gossamer Bio Price To Earning vs. Total Debt
| GOSS Stock | USD 1.16 0.12 9.38% |
For Gossamer Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gossamer Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gossamer Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gossamer Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gossamer Bio over time as well as its relative position and ranking within its peers.
Gossamer |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gossamer Bio. If investors know Gossamer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Gossamer Bio is measured differently than its book value, which is the value of Gossamer that is recorded on the company's balance sheet. Investors also form their own opinion of Gossamer Bio's value that differs from its market value or its book value, called intrinsic value, which is Gossamer Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gossamer Bio's market value can be influenced by many factors that don't directly affect Gossamer Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gossamer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gossamer Bio Total Debt vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Gossamer Bio's current stock value. Our valuation model uses many indicators to compare Gossamer Bio value to that of its competitors to determine the firm's financial worth. Gossamer Bio is rated # 3 in price to earning category among its peers. It is rated # 2 in total debt category among its peers . Total Debt To Capitalization is likely to gain to 0.92 in 2025. Comparative valuation analysis is a catch-all technique that is used if you cannot value Gossamer Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Gossamer Total Debt vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Gossamer Bio |
| = | (4.61) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Gossamer Bio |
| = | 202.88 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Gossamer Total Debt vs Competition
Gossamer Bio is rated # 2 in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 840.01 Million. Gossamer Bio totals roughly 202.88 Million in total debt claiming about 24% of equities under Health Care industry.
Gossamer Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Gossamer Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gossamer Bio will eventually generate negative long term returns. The profitability progress is the general direction of Gossamer Bio's change in net profit over the period of time. It can combine multiple indicators of Gossamer Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.2 M | 1.2 M | |
| Net Interest Income | -9.7 M | -10.2 M | |
| Interest Income | 1.8 M | 1.6 M | |
| Operating Income | -59.9 M | -62.9 M | |
| Net Loss | -56.5 M | -59.4 M | |
| Income Before Tax | -55.6 M | -58.4 M | |
| Total Other Income Expense Net | 4.3 M | 4.5 M | |
| Net Loss | -206.4 M | -216.8 M | |
| Net Loss | -56.5 M | -59.4 M | |
| Income Tax Expense | 893 K | 848.4 K | |
| Non Operating Income Net Other | 2.8 M | 2.8 M | |
| Change To Netincome | 48.9 M | 33.7 M | |
| Net Loss | (0.25) | (0.26) | |
| Income Quality | 0.06 | 0.06 | |
| Net Income Per E B T | 0.91 | 0.82 |
Gossamer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Gossamer Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gossamer Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gossamer Bio's important profitability drivers and their relationship over time.
Use Gossamer Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gossamer Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will appreciate offsetting losses from the drop in the long position's value.Gossamer Bio Pair Trading
Gossamer Bio Pair Trading Analysis
The ability to find closely correlated positions to Gossamer Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gossamer Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gossamer Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gossamer Bio to buy it.
The correlation of Gossamer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gossamer Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gossamer Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gossamer Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Gossamer Bio position
In addition to having Gossamer Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.